Chief Executive Officer · LISATA THERAPEUTICS, INC. (LSTA)

David Mazzo

A named executive officer of LISATA THERAPEUTICS in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,147,359

Salary $711,729Stock awards $307,800

FY2024: $1,691,174

1st of 3 named executive officers at Lisata Therapeutics by FY2025 total.

3 named officers on file for LISATA THERAPEUTICS, FY2025

David Mazzo’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how LISATA THERAPEUTICS’s whole pay program stands against its peers

  • LISATA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LSTA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 19, 2026 (DEF 14A).

Free

Get David Mazzo’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Mazzo compensation by year

LISATA THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as LISATA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$702,969$711,729
Bonus$387,876$0
Stock awards$468,160$307,800
Option awards$101,920$104,080
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$30,250$23,750
Total$1,691,174$1,147,359

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LISATA THERAPEUTICS, INC. DEF 14A filed October 19, 2026, accession 0001140361-26-039986, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LISATA THERAPEUTICS, INC. filed document, accession 0001140361-26-039986. Every figure is read from that document and cited to the page and table it appears in. Filed October 19, 2026.

$1.7M
$1.1M
FY24
FY25
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU60,750$112,995—
RSU47,000$87,420—
RSU15,000$27,900—
Option30,000—$3.80
Option23,500—$3.08
Option7,500—$3.00

Per the Outstanding Equity Awards at Fiscal Year-End table in LISATA THERAPEUTICS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

LISATA THERAPEUTICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
David Mazzo · this pageChief Executive Officer$1,147,359
Kristen BuckFormer Executive Vice President R&D and Chief Medical Officer$736,418
James NiscoSenior Vice President, Finance and Treasury and Chief Accounting Officer$433,464

The full LISATA THERAPEUTICS compensation record

free company brief

This page is one person within LISATA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LISATA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Mazzo's compensation dossier · One-time report. No refunds.